About P4 MICROBIOME, INC.
P4 Microbiome is a biotechnology company commercializing antimicrobial peptide therapies to correct dysbiosis and treat diseases along the GI tract. The company was founded by Johns Hopkins University professors and took over the clinical development of P4M01 from the US Army in 2020.
Development of first-in-class chewing gum containing antimicrobial peptide (P4M01)Commercialization of antimicrobial peptide therapies to restore balance to the gut’s microbial floraResearch and treatment of conditions including gingivitis, small intestinal bacterial overgrowth (SIBO), and irritable bowel syndrome (IBS)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to P4 MICROBIOME, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.